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Cannabinoid receptors play key roles in brain func-
tion, and cannabinoid effects in brain physiology
and drug-related behavior are thought to be medi-
ated by receptors present in neurons. Neuron-astro-
cyte communication relies on the expression by
astrocytes of neurotransmitter receptors. Yet, the
expression of cannabinoid receptors by astrocytes
in situ and their involvement in the neuron-astrocyte
communication remain largely unknown. We show
that hippocampal astrocytes express CB1 receptors
that upon activation lead to phospholipase C-depen-
dent Ca2+mobilization from internal stores. These re-
ceptors are activated by endocannabinoids released
by neurons, increasing astrocyte Ca2+ levels, which
stimulate glutamate release that activates NMDA re-
ceptors in pyramidal neurons. These results demon-
strate the existence of endocannabinoid-mediated
neuron-astrocyte communication, revealing that as-
trocytes are targets of cannabinoids andmight there-
fore participate in the physiology of cannabinoid-
related addiction. They also reveal the existence of
an endocannabinoid-glutamate signaling pathway
where astrocytes serve as a bridge for nonsynaptic
interneuronal communication.
INTRODUCTION
Recent evidence has demonstrated the existence of bidirec-
tional communication between astrocytes and neurons (Araque
et al., 2001; Haydon and Carmignoto, 2006; Nedergaard et al.,
2003; Volterra and Bezzi, 2002). Astrocytes respond with intra-
cellular Ca2+ elevations to neurotransmitters released by synap-
tic terminals (Perea and Araque, 2005; Porter and McCarthy,
1996) and, in turn, modulate neuronal excitability and synaptic
transmission by releasing neuroactive substances called glio-
transmitters (Araque et al., 1999; Beattie et al., 2002; Perea
and Araque, 2007; Volterra and Bezzi, 2002). Neuron-to-astro-
cyte communication is based on the expression by astrocytes
of different neurotransmitter receptors that, in many cases, are
coupled to second messenger pathways that upon activation
lead to mobilization of Ca2+ from the intracellular stores. The
presence of cannabinoid receptors in astrocytes is controversial(for a review see Stella, 2004). While some studies did not detect
cannabinoid effects on astrocytes, cannabinoid receptors have
been ultrastructurally localized in astrocytes of the caudate
putamen nucleus (Rodriguez et al., 2001) and the dorsal horn
of the spinal cord (Salio et al., 2002), and several studies have
shown their presence in cultured glial cells (Molina-Holgado
et al., 2003; Stella, 2004; Walter and Stella, 2003). Consequently,
the expression of functional cannabinoid receptors by astro-
cytes in situ remains poorly defined, and their involvement in
the neuron-astrocyte communication is unknown.
The endocannabinoid system is an important intercellular
signaling system involved in a wide variety of physiological
processes. It consists of cannabinoid receptors, endogenous
transmitters (called endocannabinoids), and the enzymatic ma-
chinery for their synthesis, release, and degradation. Two types
of cannabinoid receptors, termedCB1Rs andCB2Rs, have been
characterized, and the existence of additional receptors has
been suggested (Matsuda et al., 1990; Munro et al., 1993). While
CB2Rs are mainly expressed by cells of the immune system,
CB1Rs are highly expressed in many brain regions, where they
play relevant neuromodulatory roles in brain physiology (Cheva-
leyre et al., 2006; Freund et al., 2003; Rodriguez et al., 2001).
CB1Rs mediate retrograde inhibition of transmitter release,
control neuronal excitability, and regulate short- and long-term
synaptic plasticity (Alger, 2002; Chevaleyre et al., 2006; Freund
et al., 2003; Kreitzer and Regehr, 2002; Wilson and Nicoll,
2002). Furthermore, these receptors are responsible for most
of the psychotropic and behavioral effects of cannabinoids (Mal-
donado et al., 2006; Di Marzo et al., 2004). Cannabinoid effects
in brain physiology are thought to be mediated by CB1Rs exclu-
sively present in neurons. Indeed, numerous studies have fo-
cused on the CB1 expression by different subpopulations of
neurons in different brain areas, but the possible functional
expression of cannabinoid receptors by astrocytes in situ has
been largely disregarded.
The identification of all of the cellular mechanisms involved in
cannabinoid signaling is essential for a full understanding of its
cellular bases and physiological consequences. Therefore, we
used electrophysiological and Ca2+ imaging techniques in mice
brain slices to investigate the functional expression of cannabi-
noid receptors by hippocampal astrocytes and their participa-
tion in the neuron-astrocyte communication. We found that hip-
pocampal astrocytes express functional CB1Rs, which upon
activation lead to phospholipase C-dependent Ca2+mobilization
from internal stores. These receptors can be activated by endo-
cannabinoids released from pyramidal neurons, increasing the
astrocyte Ca2+ levels and stimulating the release of glutamate,Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc. 883
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Endocannabinoids and Neuron-Astrocyte SignalingFigure 1. Cannabinoid Receptor Activation Increases Ca2+ Levels in
Astrocytes
(A) Pseudocolor images representing fluorescence intensities of a fluo-4-filled
hippocampal astrocyte of CA1 stratum radiatum 10 s before and 2 and 40 s
after local application of WIN delivered by pressure pulse from a micropipette.
Scale bar, 15 mm.
(B) Astrocytic Ca2+ levels evoked by local application (horizontal bars) of 2AG,
AEA, and WIN in control and 2 mM AM251.
(C and D) Proportion of responding astrocytes and relative fluorescence
changes induced by CB1R agonists in control (white bars) and test conditions
(black bars). The cocktail contained TTX and glutamatergic, GABAergic, cho-
linergic, and purinergic receptor antagonists (see Results). Each bar, R30
astrocytes from nR 4 slices. Error bars indicate SEM. Significant differences
were established at *p < 0.05 and ***p < 0.001.884 Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc.which signals back to neurons activating NMDARs, evoking slow
inward current in pyramidal neurons.
RESULTS
Hippocampal Astrocytes Express Functional
Endocannabinoid Receptors that Mediate Intracellular
Calcium Elevations
To investigate whether hippocampal astrocytes express func-
tional endocannabinoid receptors, we recorded the intracellular
Ca2+ levels of astrocytes located in the stratum radiatum of the
CA1 region and analyzed the responses to local application of
endogenous as well as synthetic agonists of these receptors.
Local application of 2-arachidonylglycerol (2AG), arachidonyle-
thanolamide (AEA), (R)-(+)-methanandamide (MAEA), or (R)-(+)-
WIN 55,212-2 (WIN) by pressure pulses through a micropipette
increased the intracellular Ca2+ levels in 125 out of 169 astro-
cytes (from a representative sample of n = 21 slices; Figures
1A–1C). The number of responding astrocytes and the relative
fluorescence change evoked by the agonists were inhibited by
the selective antagonist of CB1Rs, AM251 (2 mM; Figures 1B–
1D and Figure S1A available online), indicating that the observed
Ca2+ elevations were mediated by CB1R activation.
Astrocytic responses could be indirectly evoked by CB1R
agonists because CB1Rs are largely present in glutamatergic
and GABAergic synaptic terminals where they can inhibit synap-
tic transmitter release (Alger, 2002; Chevaleyre et al., 2006;
Freund et al., 2003; Llano et al., 1991; Rodriguez et al., 2001).
Therefore, we analyzed the astrocytic responses to the local
application of the CB1R agonist WIN before and after blocking
glutamatergic, GABAergic, cholinergic, and purinergic receptors
with a cocktail containing CNQX (20 mM; for AMPA and kainate
glutamate receptors), AP5 (50 mM; for NMDA glutamate recep-
tors), MPEP (50 mM; for metabotropic glutamate receptors
mGluR5), LY367385 (100 mM; for metabotropic glutamate recep-
tors mGluR1), picrotoxin (50 mM; for GABAA receptors), saclofen
(100 mM; for GABAB receptors), atropine (50 mM; for muscarinic
cholinergic receptors), CPT (10 mM; for A1 adenosine receptors),
and suramin (100 mM; for P2 purinergic receptors). The cocktail
also contained TTX (1 mM) to prevent action potential-mediated
neurotransmitter release. The proportion of responding astro-
cytes and the amplitude of the WIN-evoked Ca2+ elevations
were not significantly affected by the cocktail of receptor antag-
onists, suggesting that the observed responses were directly
mediated by CB1R activation in astrocytes. Furthermore, Ca2+
elevations in response to WIN were absent in 27 out of 30 astro-
cytes tested in five hippocampal slices from transgenic mice
lacking CB1R expression (Zimmer et al., 1999) (Figure 2). These
astrocytes were able to respond with Ca2+ elevations to ATP
application, indicating that transmitter receptor-mediated Ca2+
(E) Immunocytochemical localization of GFAP and CB1R in stratum radiatum
hippocampal astrocytes. Top images show staining for GFAP and CB1R and
their colocalization (left to right). The astrocytic process marked with a box
in the merged image was magnified (bottom images). Images were obtained
by laser-scanning confocal microscopy constructed from a stack of four
successive images (1 mm deep). Scale bars, 20 and 3 mm (top and bottom,
respectively).
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mice (22 out of 23 astrocytes; data not shown). This result con-
firms that CB1Rs were responsible for the observed astrocytic
Ca2+ elevations.
Astrocytes express a wide variety of receptors for many neu-
rotransmitters, and some of them are coupled to different G pro-
teins (Porter and McCarthy, 1997). CB1Rs are mainly coupled to
pertussis toxin (PTX)-sensitive Gi/o proteins that regulate cAMP
levels. In addition, a recent report indicates that these receptors
can also be coupled to Gq/11 proteins that activate PLC (Lauck-
ner et al., 2005). We used pharmacological tools to investigate
the intracellular signaling pathway involved in the CB1R-medi-
ated astrocytic responses. First, we investigated the nature of
the G protein involved by incubating the slices with 7.5 mg/ml
PTX for 4–8 hr and analyzing the astrocyte Ca2+ signal. To asses
the effectiveness of PTX treatment, we first applied GABA, which
evokes Ca2+ elevations mediated by GABAB receptors (Kang
et al., 1998; Serrano et al., 2006), which are known to be coupled
to Gi/o proteins (Catsicas andMobbs, 2001). GABA-evoked Ca
2+
elevations regularly observed in control slices (21 out of 38 astro-
cytes from seven slices) were absent in 24 out of 29 astrocytes
from four slices pretreated with PTX (data not shown). In con-
trast, in those PTX-treated slices, the proportion of astrocytes
that responded with Ca2+ elevations to local application of WIN
was similar to control slices (Figure 1C), indicating that CB1R-
induced astrocyte Ca2+ signal was not mediated by PTX-sensi-
tive G proteins.
Figure 2. Astrocyte Ca2+ Levels Are Unaffected by Cannabinoids in
CB1R/ Mice
(A) Pseudocolor images representing fluorescence intensities of fluo-4-filled
astrocytes in hippocampal slices from wild-type and CB1R/ mice before
and 8 s after local application of WIN. Scale bars, 7 mm.
(B) Astrocyte Ca2+ levels evoked by local application of WIN (horizontal bars),
in wild-type and CB1R/ mice.
(C) Proportion of responding astrocytes to WIN application in wild-type and
CB1R/mice. Each bar,R30 astrocytes from nR 8 slices. Error bars indicate
SEM. Significant differences were established at ***p < 0.001.Next, we analyzed the participation of the intracellular Ca2+
stores by perfusing the slices with thapsigargin, which depletes
them by inhibiting the Ca2+ ATPase (Araque et al., 1998). After
control recordings, the sliceswere perfusedwith 1 mM thapsigar-
gin for 30–45 min. The WIN-evoked astrocytic Ca2+ elevations
were diminished by thapsigargin (Figure 1C), indicating that
they require the presence of intact intracellular Ca2+ stores.
The PLC antagonists U73122 (4 mM) and ET-18-OCH3 (15 mM)
also decreased the WIN-evoked Ca2+ elevations (Figure 1D),
indicating that Ca2+ elevations evoked by cannabinoids in astro-
cytes are mediated by CB1Rs that activate PLC, probably
through a Gq/11 protein, and mobilize Ca
2+ from internal stores.
Besides the functional expression of CB1Rs in astrocytes, to
obtain morphological evidence of CB1R presence in astrocytes,
we performed immunocytochemical analysis using antibodies
against CB1Rs and GFAP (a specific marker of astrocytes).
CB1R signal could be observed in astrocytic processes identi-
fied by their GFAP staining in stratum radiatum hippocampal as-
trocytes (Figure 1E).
Astrocytes Respond with Intracellular Calcium
Elevations to Neuronal Depolarization
Hippocampal pyramidal neurons are known to be a source of en-
docannabinoids that can be released under different experimen-
tal conditions, such as neuronal depolarization or postsynaptic
metabotropic glutamate receptor activation (Alger, 2002; Cheva-
leyre et al., 2006; Kreitzer and Regehr, 2002).We therefore inves-
tigated whether the CB1R-mediated intracellular Ca2+ signal in
astrocytes can be endogenously evoked by endocannabinoids
released fromCA1pyramidal neurons.We electrophysiologically
recorded CA1 pyramidal neurons, monitored Ca2+ levels in adja-
cent astrocytes (within a 150 mm wide region perpendicular to
the stratum pyramidale), and depolarized the neuron to 0 mV
to stimulate endocannabinoid release (Chevaleyre and Castillo,
2003; Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001;
Wilson and Nicoll, 2001).
In relatively quiescent astrocytes, neuronal depolarization (ND)
evoked a slow, transient Ca2+ elevation in adjacent astrocytes
(17 out of 31 astrocytes from four slices; see Movie S1). These
astrocytic responses could be reliably evoked by successive
neuronal stimuli and were reversibly abolished by 2 mM AM251
(n = 13; Figure 3B). Most hippocampal astrocytes display spon-
taneous Ca2+ oscillations that can be modulated by different
neurotransmitters (Nett et al., 2002; Perea and Araque, 2005).
We therefore analyzed the effects of neuronal depolarization
(ND) on the Ca2+ signal of several astrocytes in the field of view
(from 8 to 14 astrocytes), quantifying two parameters, i.e., the
probability of occurrence of a Ca2+ elevation (Ca2+ spike) and
the mean frequency oscillation 50 s before (basal) and after the
onset of the ND (Figures 3C–3G). In 11 hippocampal slices,
49% ± 4% of the astrocytes increased their Ca2+ oscillation
frequency after neuronal depolarization (Figures 3F and 3G),
while the relative mean amplitudes of the Ca2+ elevations were
unchanged (mean amplitude of the Ca2+ signal during ND was
86.1%± 13.1% relative to corresponding basal amplitudes). Fur-
thermore, theCa2+ spike probability was transiently increased by
ND (n = 7; Figure 3E). These effects could be consistently evoked
by successive neuronal stimuli (Figure 4A) and depended on theNeuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc. 885
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together, these results indicate that neuronal depolarization
modulates the Ca2+ signal of adjacent astrocytes, evoking intra-
cellular Ca2+ elevations in relatively silent astrocytes, increasing
the oscillation frequency of oscillating astrocytes, and increasing
the probability of occurrence of Ca2+ elevations.
Interestingly, while most astrocytes showed Ca2+ elevations
upon exogenous local stimulation with cannabinoids (85.8% ±
4.5% of 42 astrocytes from six slices, see Figure 1), astrocytic
Ca2+ signal modulation by ND was observed in a subset of
astrocytes (49.2% ± 4.0% of 105 astrocytes from 11 slices).
However, astrocytes consistently responded or not to the suc-
cessive stimulation of a given neuron, i.e., astrocytes respond-
ing to the first ND also responded to the second ND, while non-
responding astrocytes to the first stimulus did not respond to
the second ND either (Figure 4B). Furthermore, nonresponding
astrocytes to ND were able to respond with Ca2+ elevations
upon exogenous stimulation with WIN (16 out of 18 astrocytes
from four slices; data not shown). These results indicate that
astrocytic responses did not result from a wide spillover of
endocannabinoids and suggest the existence of intercellular
signaling endocannabinoid pathways between neurons and
astrocytes.
Because endocannabinoid signaling might be affected by
temperature (Kreitzer et al., 2002), we investigated whether
astrocytic responses to endocannabinoids were also present
at more physiological temperature (34C). The increase of the
Ca2+ spike probability and the Ca2+ oscillation frequency evoked
Figure 3. Neuronal Depolarization Increases Ca2+
Signal in Hippocampal Astrocytes
(A) Schematic drawing and infrared differential interference
contrast image showing the stratum radiatum (SR) and the
recorded neuron in the stratum pyramidale (SP). Scale bar,
20 mm.
(B) (Top) Pseudocolor images representing astrocyte fluores-
cence intensities before and after neuronal depolarization
(ND); (bottom) astrocyte Ca2+ levels evoked by ND (horizontal
bars) in control and AM251. Scale bar, 15 mm.
(C) Pseudocolor image of a representative field of view show-
ing eight hippocampal astrocytes in the stratum radiatum.
Scale bar, 40 mm.
(D) Ca2+ levels from five astrocytes in a field of view and
corresponding average traces (gray) in control and AM251.
Horizontal bars indicate ND.
(E) Astrocyte Ca2+ spike probability versus time (n = 7 slices).
Time 0 corresponds to the beginning of the ND.
(F) Relative number of astrocytes that increased their Ca2+
oscillation by ND in control, AM251, and after washout (n =
37 astrocytes from four slices).
(G) Mean Ca2+ oscillation frequency before (basal) and after
ND. Error bars indicate SEM. Significant differences were
established at **p < 0.01 and ***p < 0.001.
by ND, as well as the proportion of responding
astrocytes (55% ± 3% at 24C and 57% ± 6%
at 34C), were not significantly different at 24C
and 34C (n = 48 astrocytes from six slices) (Fig-
ure 4C), indicating that endocannabinoid-mediated
neuron-astrocyte signaling occurs under physiological condi-
tions.
Endocannabinoids Released by Pyramidal Neurons
Evoke Astrocyte Calcium Elevations
To investigate the cellular mechanisms involved in the ND-
evoked astrocytic Ca2+ elevation, we compared the astrocyte
Ca2+ signal parameters (i.e., Ca2+ oscillation frequency andprob-
ability of Ca2+ elevation) before and after different pharmacolog-
ical treatments (Figures 4D and 4E). The ND-evoked increase of
the astrocyte Ca2+ signal was not prevented in the presence of
TTX or after dialyzing the stimulating neuron with QX-314, which
intracellularly blocks voltage-gated Na+ currents, suggesting
that the observed effects of ND were not due to action poten-
tial-mediated neural network activation. Consistent with results
obtained by local application of CB1R agonists, ND-evoked
increases in both Ca2+ oscillation frequency and Ca2+ elevation
probability were unaffected in the presence of the cocktail of
neurotransmitter receptor antagonists, but they were abolished
by the CB1R antagonist AM251 (2 mM). In agreement with these
results, modulation of the astrocyte Ca2+ signal by ND was not
observed in slices from CB1R/ transgenic mice (n = 34 astro-
cytes from five slices; Figures 4D and 4E), indicating that the
increase of the astrocyte Ca2+ oscillations evoked by ND was
selectively mediated by CB1R activation.
To investigate the intracellular signaling pathway involved, we
incubated thesliceswith7.5mg/mlPTX.After assessing theeffec-
tiveness of PTX treatment by confirming the absence of astrocyte886 Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc.
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GABA (31 out of 36 astrocytes from five slices did not respond
to GABA; data not shown), we tested the effects of ND on the as-
trocyte Ca2+ oscillations. Although a slight reduction of the basal
oscillation frequency was observed in PTX-treated slices (proba-
bly due to the deleterious effects of PTX on cellular viability), both
Figure 4. Astrocytic Ca2+ Elevations Evoked by Neuronal Depolar-
ization Are Mediated by CB1R Activation
(A) Astrocyte Ca2+ spike probability evoked by successive ND (horizontal bars)
(n = 37 astrocytes from four slices).
(B) Proportion of astrocytes that responded to two successive ND. Note that
almost all of the astrocytes either responded (+) or not (–) to the first and sec-
ond stimuli (n = 123 astrocytes from ten slices).
(C) Astrocyte Ca2+ spike probability and Ca2+ oscillation frequency before
(basal; open symbols) and after neuronal depolarization (ND; filled symbols)
at 24C and 34C (48 astrocytes from six slices). Gray symbols indicate
mean values.
(D and E) Astrocyte Ca2+ oscillation frequency and Ca2+ spike probability, re-
spectively, before (basal; white bars) and after neuronal depolarization (ND;
black bars) in control and test conditions (n R 5 slices for each bar). Error
bars indicate SEM. Significant differences were established at *p < 0.05,
**p < 0.01.theCa2+ oscillation frequencyand theCa2+ spikeprobabilitywere
significantly increased after neuronal depolarization (Figures 4D
and 4E). In contrast, the PLC antagonists U73122 (4 mM) and
ET-18-OCH3 (15 mM) abolished the astrocytic response to ND.
Taken together, these results indicate that the intracellular Ca2+
elevations evoked in astrocytes byNDaremediated byCB1Rac-
tivation that stimulates PLC.
We then investigated whether the ND-induced increase of
the astrocyte Ca2+ signal was mediated by endocannabinoids
released from pyramidal neurons. Neuronal depolarization stim-
ulates the release of endocannabinoids, which transiently re-
duces inhibitory transmitter release by activation of presynaptic
CB1Rs, a process known as depolarization-induced suppres-
sion of inhibition (DSI) (for review see Alger 2002; Freund et al.,
2003; Chevaleyre et al., 2006). Using DSI as bioassay for endo-
cannabinoid release, we compared the effects of ND on the DSI
in neurons and the Ca2+ spike probability in astrocytes by simul-
taneously recording inhibitory postsynaptic currents (IPSCs)
from pyramidal neurons and astrocyte Ca2+ levels (Figures 5A
and 5B). Increasing the duration of the ND induced a gradual in-
crease of both the proportion of DSI and the astrocyte Ca2+
spike probability (Figures 5C and 5D). Both parameters showed
a high degree of correlation (r2 = 0.83). These results suggest
that astrocyte Ca2+ signal results from endocannabinoids re-
leased from pyramidal neurons and indicate that endocannabi-
noids are similarly effective in inducing neuronal and astrocytic
effects.
Because endocannabinoid release by neuronal depolarization
requires the increase of neuronal intracellular Ca2+ (Chevaleyre
and Castillo, 2003; Kreitzer and Regehr, 2001; Ohno-Shosaku
et al., 2001; Wilson and Nicoll, 2001), to further test the idea
that astrocyte Ca2+ elevations were induced by endocannabi-
noids released by neurons, we selectively manipulated the intra-
cellular Ca2+ levels in the pyramidal neuron. First, we performed
paired whole-cell recordings from two adjacent pyramidal neu-
rons (Figures 6A and 6B). One recording pipette included the
Ca2+ chelator BAPTA (20 mM) to prevent Ca2+ rises in one pyra-
midal neuron, while the other neuron, filled with standard intra-
cellular solution, was used as a control. While depolarization of
the control neuron increased both the Ca2+ spike probability
and the Ca2+ oscillation frequency in astrocytes, depolarization
of the BAPTA-filled neuron did not affect the astrocyte Ca2+
signal (Figure 6B). Second, in another set of experiments, the re-
corded neuron was loaded through the recording pipette with
the Ca2+-cage NP-EGTA to selectively increase its Ca2+ levels
after UV-flash photolysis stimulation. These experiments were
performed in the presence of TTX to prevent action potential-
evoked neurotransmitter release. UV-flash stimulation elevated
neuronal Ca2+ and increased the astrocyte Ca2+ spike probabil-
ity (Figures 6C–6F). In the absence of NP-EGTA-loaded neurons,
UV-flashes did not modify astrocyte Ca2+ levels (Figure 6F), indi-
cating that the effects were not due to direct photostimulation of
astrocytes.
Taken together, these results indicate that Ca2+ elevations in
pyramidal neurons are necessary and sufficient to induce Ca2+
elevations in astrocytes and further support the idea that the
CB1R-mediated astrocyte Ca2+ responses to ND were evoked
by endocannabinoids released from pyramidal neurons.Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc. 887
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Endocannabinoid-Mediated DSI Depended
on ND Duration
(A) IPSCs before (basal), 3 s after ND, and 20 s later
(recovery).
(B) Mean relative IPSC amplitudes (n = 6 neurons).
Zero time corresponds to ND (for 5 s; horizontal
bar).
(C) Simultaneously recorded DSI and astrocyte
Ca2+ spike probability evoked at different ND du-
ration (n R 5 for each point). Error bars indicate
SEM.
(D) Corresponding plot of astrocyte Ca2+ spike
probability change from basal versus DSI. Points
were fitted to a linear regression (straight line;
r2 = 0.83).CB1R-Mediated Calcium Elevations in Astrocytes
Evoke Glutamate-Mediated Slow Inward Currents
in Pyramidal Neurons
We next investigated the physiological consequences of the en-
docannabinoid-mediated astrocyte Ca2+ elevations on neuronal
excitability. Recent reports indicate that exogenous experimen-
tal stimuli (extracellular application of ATP or the mGluR agonist
DHPG, astrocytic depolarization, or photorelease of intracellular
Ca2+ from Ca2+-caged compounds) that elevate intracellular
Ca2+ in astrocytes induce glutamate-mediated slow inward cur-
rents (SICs) in adjacent neurons (Angulo et al., 2004; Araque
et al., 1998; Fellin et al., 2004; Perea and Araque, 2005). We
then asked whether endocannabinoids released by pyramidal
neurons may serve as endogenous signals that, by elevating
the astrocytic Ca2+, stimulate the release of glutamate from as-
trocytes. We simultaneously recorded whole-cell currents from
two nearby pyramidal neurons as well as the Ca2+ levels from
adjacent astrocytes, in the presence of the cocktail containing
neurotransmitter receptor antagonists (except AP5) and TTX
and in the absence of extracellular Mg2+ to maximize NMDAR
activation. Because the observation of SICs during neuronal
depolarization was prevented in the stimulating neuron, currents
were analyzed in the nonstimulated neuron. Under these condi-
tions, pyramidal neurons displayed a basal frequency of SICs of
1.3 ± 0.4 min1 (mean SIC amplitude: 34 ± 4 pA; n = 36; cf. An-
gulo et al., 2004; Fellin et al., 2004; Perea and Araque, 2005). De-
polarization of one pyramidal neuron (to 0 mV for 20 s) increased
the Ca2+ oscillation frequency in astrocytes and concomitantly
increased the frequency of SICs in the adjacent neuron (Figure 7).
SICs were totally abolished by 50 mM AP5, confirming that they
were due to NMDAR activation (Angulo et al., 2004; Fellin
et al., 2004; Perea and Araque, 2005), while the Ca2+ oscillation
frequency increase was unaffected. In contrast, the ND-evoked
frequency increase of both Ca2+ oscillations and SICs were pre-
vented by 2 mM AM251, which did not significantly modify their
basal frequency. In the presence of extracellular Mg2+, the fre-
quency of SICs, detected as AP5-sensitive outward currents at888 Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc.depolarized membrane potentials (>30 mV), was also increased
after ND (from 1.4 ± 0.4 to 3.1 ± 0.6; n = 4; Figure 7E), indicating
that this phenomenon also occurs under normal extracellular
Ca2+ andMg2+ concentrations. Altogether, these results indicate
that CB1R-mediated Ca2+ elevations in astrocytes are required
for the SIC frequency increase induced by neuronal depolariza-
tion.
Therefore, we hypothesized that these effects were due to
stimulation of endocannabinoid release by neuronal depolariza-
tion. To test this hypothesis, we included BAPTA in one of the
recording pipettes to prevent Ca2+ rises and endocannabinoid
release from one neuron, while the other neuron remained as
a control. Depolarization of the control neuron increased the
frequency of both astrocytic Ca2+ oscillations and SICs in the
adjacent neuron. In contrast, depolarization of the BAPTA-filled
neuron did not significantly modify the basal frequency of both
parameters (Figure 7D).
To test whether endocannabinoid-mediated Ca2+ elevations
in astrocytes are necessary to stimulate glutamate release and
increase the frequency of SICs, we analyzed the effects of de-
pleting the internal Ca2+ stores with thapsigargin. We first tested
whether ND-evoked endocannabinoid release still occurred after
30 min incubation with 1 mM thapsigargin by recording IPSCs to
monitor the amount of DSI, as indicative of endocannabinoid
release. DSI could be observed in thapsigargin (although with
a relatively smaller amplitude than in control; cf. Isokawa and
Alger, 2006), indicating that ND-evoked endocannabinoid re-
lease was not prevented by thapsigargin (Figure 8A). Then, in
parallel experiments, we simultaneously recorded whole-cell
currents from two pyramidal neurons and Ca2+ signals from as-
trocytes. The ND-evoked increase of both astrocyte Ca2+ spike
probability and frequency of SICs observed in control condi-
tions, were abolished after incubation with thapsigargin (Figures
8B and 8C). These results indicate that endocannabinoid release
from neurons requires astrocytic Ca2+ elevations to stimulate
glutamate release from astrocytes and increase the frequency
of SICs in pyramidal neurons.
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Endocannabinoids and Neuron-Astrocyte SignalingFigure 6. Astrocytic Ca2+ Elevations Are Mediated by Endocannabi-
noids Released from Pyramidal Neurons
(A) Infrared differential interference contrast image and schematic drawing
showing simultaneous recording from two pyramidal neurons. One recording
pipette included 40 mM BAPTA to prevent Ca2+ rises in one pyramidal neuron,
while the other neuron was filled with standard intracellular solution (Control).
Scale bar, 25 mm.
(B) Representative traces of Ca2+ levels from six astrocytes in a typical field of
view (top) and astrocyte Ca2+ spike probability (bottom) before and after depo-
larization (horizontal bars) of control and BAPTA-filled neurons (left and right,
respectively) (n = 9 slices).
(C) Schematic drawing.
(D) (Left) Image showing fluorescence intensities of NP-EGTA and fluo-4-filled
neuron in stratum pyramidale. Scale bar, 15 mm. (Right) Neuron Ca2+ levels
evoked by UV-flash stimulation in the soma.
(E) Astrocyte Ca2+ spike probability versus time (n = 6 slices). Zero time corre-
sponds to the beginning of UV-flash stimulation (horizontal bar).Taken together, these results indicate that depolarization of
neurons stimulates the release of endocannabinoids, which
activate CB1Rs in astrocytes, elevating their intracellular Ca2+
and inducing the release of glutamate, which in turn serves as
a feedback signal activating NMDARs in neurons.
DISCUSSION
The expression of CB1Rs by different neuronal populations is
well documented (for reviews see Freund et al., 2003; Piomelli,
2003). However, their expression by astrocytes both in culture
and in situ is controversial (e.g., see Stella, 2004). The reported
experimental discrepancies may arise from the well-known phe-
notypic changes of astrocytes in different culture conditions.
Nevertheless, although ultrastructural studies detected CB1Rs
in astrocytes of specific brain areas (Rodriguez et al., 2001; Salio
et al., 2002) and several studies showed CB1Rs in cultured glial
cells (Molina-Holgado et al., 2003; Stella, 2004; Walter and
Stella, 2003), their functional expression by astrocytes in situ
remained unclear. Here we show that hippocampal astrocytes
in situ express functional CB1Rs that can play a relevant role in
intercellular signaling in the nervous system.
CB1Rs belong to the G protein-coupled seven-transmem-
brane receptor (GPCR) superfamily (Matsuda et al., 1990). They
are preferentially coupled to PTX-sensitive Gi/o proteins (Mackie
and Hille, 1992; Piomelli, 2003), and they can activate PLC in
a PTX-sensitive manner mediated by the Gi/o bg subunits (Fili-
peanu et al., 1997; Lograno and Romano, 2004; Netzeband
et al., 1999; Sugiura et al., 1997). Furthermore, Lauckner et al.
(2005) have reported that CB1Rs can also be coupled to Gq/11
proteins in an agonist-specific manner, because WIN, but no
other agonists, activated Gq/11 and PLC in HEK293 transfected
cells and cultured neurons, challenging the classical idea that
GPCRs specifically interact with certain types of G proteins.
These authors hypothesized that CB1 interaction with Gq/11
proteins may occur under different conditions, such as during
agonist-dependent conformation stabilization of receptors, at el-
evated receptor occupancy, or when the ratio betweenGq/11 and
Gi/o proteins is high. If such is the case, present results suggest
that interaction of CB1Rs with Gq/11 proteins may be more
favored in astrocytes than in neurons. Moreover, the present
demonstration that CB1R activation by endocannabinoids leads
to Ca2+ mobilization through activation of PLC in a PTX-insensi-
tive manner indicates that CB1Rs can be naturally coupled to
Gq/11 proteins and suggests that the promiscuity of GPCRs and
G proteins may be a general phenomenon with physiological
bases and consequences.
Several studies have shown the prominent role of CB1Rs
triggering different intracellular signaling cascades other than in-
tracellular Ca2+ elevations (see Chevaleyre and Castillo, 2003;
Freund et al., 2003; Kreitzer and Regehr, 2002). Furthermore,
CB1Rs can evoke Ca2+ rises by either activation of Gi/o bg
proteins (Filipeanu et al., 1997; Lograno and Romano, 2004; Net-
zeband et al., 1999; Sugiura et al., 1997), L-type Ca2+ channel
(F) Mean Ca2+ oscillation frequency before (basal) and after UV-flash stimula-
tion of control or NP-EGTA-filled neurons. Error bars indicate SEM. Significant
differences were established at *p < 0.05.Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc. 889
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Endocannabinoids and Neuron-Astrocyte SignalingFigure 7. Endocannabinoid-Induced Astrocyte Ca2+
Elevations Evoke NMDAR-Mediated SICs in Pyramidal
Neurons
(A) Intracellular Ca2+ levels from three astrocytes (red traces) and
whole-cell currents from adjacent neurons (black and blue traces).
The experimental arrangement is as in Figure 6A, i.e., in paired
recordings, one neuronwas filledwith BAPTA,while the other neu-
ron was filled with standard solution (Control). Horizontal bars
indicate neuronal depolarization. Recordings were obtained dur-
ing depolarization of the control neuron (Control), the BAPTA-filled
neuron, and the control neuron in the presence of AP5. Asterisks
indicate slow inward currents (SICs). Two SICs have been ex-
panded (blue traces).
(B) Astrocyte Ca2+ spike probability (red) and mean number of
neuronal SICs (blue) before and after neuronal depolarization (hor-
izontal bars) of the control neuron (left), the BAPTA-filled neuron
(center), and the control neuron in AP5 (right) (18 paired recorded
neurons from n = 9 slices).
(C) Frequency of astrocytic Ca2+ oscillations and SICs 50 s before
(basal; white bars) and after neuronal depolarization (ND; black
bars) of control neurons in control solution and in the presence
of AM251, AP5, or both antagonists (nR 5 slices for each bar).
(D) Frequency of astrocytic Ca2+ oscillations and SICs 50 s before
(basal; white bars) and after ND (black bars) of control and BAPTA-
filled neurons (n = 8 slices).
(E) Whole-cell currents from a pyramidal neuron recorded at
+30 mV in the presence of TTX and extracellular Mg2+. SICs de-
tected as outward currents are marked by asterisks, and two
SICs have been expanded (lower traces). Frequency of SICs 50
s before (basal; white bars) and after neuronal depolarization
(ND; black bars) in control solution and in the presence of AP5
(n = 4 slices for each bar). Error bars indicate SEM. Significant dif-
ferences were established at *p < 0.05, **p < 0.01, and #p < 0.001.
these processes is an exciting hypothesis that
deserves investigation.
Because astrocyte-evoked SICsmay influence neu-
ronal excitability and synchronization (Angulo et al.,
2004; Araque et al., 1998; Fellin et al., 2004), the endo-
cannabinoid-induced astrocyte-mediated SICs may
have a relevant physiological significance on neuronal
activity. The fact that SICs are mediated by NMDA
receptors, which require the depolarization of the
postsynaptic neuron to open under physiological con-
ditions, suggests that this astrocyte-neuron signaling
needs the coincidence of neuronal and astrocytic
activity.modulation (Rubovitch et al., 2002), or agonist-specific activa-
tion of Gq/11 proteins (Lauckner et al., 2005). Here we have
shown that CB1R activation causes astrocyte Ca2+ elevations
that evoke glutamate-mediated astrocyte-neuron signaling, re-
vealing a physiological role for this CB1R-evoked Ca2+ signaling.
Endocannabinoid signaling plays important roles in synaptic
function (Alger, 2002; Chevaleyre et al., 2006; Kreitzer and Re-
gehr, 2002; Walter and Stella, 2003). Considering recent data
demonstrating the relevance of neuron-astrocyte communica-
tion in brain physiology (Araque et al., 2001; Haydon, 2001; Hay-
don and Carmignoto, 2006; Nedergaard et al., 2003; Perea and
Araque, 2007; Volterra and Meldolesi, 2005), whether endocan-
nabinoid signaling between neurons and astrocytes is involved in890 Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc.CB1Rs are known to mediate cannabinoid effects in drug-
related behavior (Maldonado et al., 2006). These effects are
thought to be mediated by the direct control of neural network
activity. However, present evidence raise the possibility that
direct activation of CB1Rs in astrocytes may be a primary cause
involved in the cannabinoid effects. Hence, the fact that astro-
cytes express functional CB1Rs must be considered when
interpreting the cellular basis of the behavioral effects of
cannabinoids.
In conclusion, we provide evidence indicating that astrocytes
express CB1Rs that upon activation by endocannabinoids
released from pyramidal neurons lead to PLC-dependent Ca2+
mobilization from internal stores. This endocannabinoid-induced
Neuron
Endocannabinoids and Neuron-Astrocyte Signalingastrocyte Ca2+ signal may signal back to neurons through the re-
lease of glutamate that activates NMDARs in pyramidal neurons.
These results indicate that neurons and astrocytes communicate
via endocannabinoid signaling and suggest the existence of
intercellular communication pathways mediated by endocanna-
binoid-glutamate signaling where astrocytes serve as a bridge
for interneuronal communication.
Present results reveal that astrocytes are cellular targets of
cannabinoids, identifying these cells as cellular elements possi-
bly involved in the physiology of cannabinoid addiction as well as
potential targets for the treatment of cannabinoid-related drug
abuse. Furthermore, considering the importance of the endo-
Figure 8. Endocannabinoid-Induced Astrocyte Ca2+ Elevations Are
Necessary to Evoke SICs in Pyramidal Neurons
(A) IPSC amplitude before and after 5 s ND in control (left) and 1 mM thapsigar-
gin (n = 4). Zero time corresponds to ND (horizontal bar).
(B) Astrocyte Ca2+ spike probability (red) and mean number of neuronal SICs
(blue) before and after neuronal depolarization (horizontal bars) in control
(left) and 1 mM thapsigargin (ten paired recorded neurons from n = 5 slices).
(C) Frequency of astrocytic Ca2+ oscillations and SICs 50 s before (basal; white
bars) and after ND (black bars) in control and thapsigargin (n = 5 slices). Error
bars indicate SEM. Significant differences were established at **p < 0.01 and
***p < 0.001.
(D) Schematic drawing representing the endocannabinoid-mediated neuron-
to-astrocyte signaling and the subsequent glutamate-mediated astrocyte-to-
neuron signaling.cannabinoid-mediated intercellular signaling in numerous pro-
cesses of the nervous system, such as pain perception or learn-
ing and memory, present findings indicate that astrocytes may
be actively involved in relevant phenomena of brain physiology.
EXPERIMENTAL PROCEDURES
Hippocampal Slice Preparation
Acute hippocampal sliceswereobtainedaspreviouslydescribed (Araqueet al.,
2002; Perea and Araque, 2005). All the procedures for handling and sacrificing
animals followed the European Commission guidelines (86/609/CEE) andwere
supervised by the Instituto Cajal veterinary officer. CD1 andC57BL/6mice (12–
17 days old) were anesthetized and then decapitated. The brain was rapidly
removedandplaced in ice-cold artificial cerebrospinal fluid (ACSF). Brain slices
(350–400 mmthick)were cutwith aVibratome (Pelco 101, Series 1000, St Louis,
MO) and incubatedduring>1hr at room temperature (21C–24C) inACSF. The
ACSF contained (in mM) NaCl 124, KCl 2.69, KH2PO4 1.25, MgSO4 2, NaHCO3
26, CaCl2 2, and glucose 10 and was gassed with 95% O2/5% CO2 (pH = 7.3).
Slices were then transferred to an immersion recording chamber and super-
fused with gassed ACSF. In experiments designed to optimize NMDAR activa-
tion, the extracellularMg2+wasequimolarly substitutedbyCa2+, and10mMgly-
cine was added. Cells were visualized under an Olympus BX50WI microscope
(Olympus Optical, Tokyo, Japan) equipped with infrared and differential inter-
ference contrast imaging devices and with a 403 water-immersion objective.
In some cases, slices from CB1 receptor knockout mice, generously donated
by Dr. A. Zimmer, were used (Zimmer et al., 1999).
Electrophysiology
Electrophysiological recordings of CA1 hippocampal pyramidal neurons and
astrocytes were made using the whole-cell patch-clamp technique. Patch
electrodes were fabricated from borosilicate glass capillaries and had resis-
tances of 6–10 MU when filled with the internal solution that contained (in
mM) KMeSO4 100, KCl 50, HEPES 10, ATP-Na2 4 (pH = 7.3). Recordings
were obtained with PC-ONE amplifiers (Dagan Instruments, Minneapolis,
MN). Fast and slow whole-cell capacitances were neutralized, series resis-
tance was compensated (about 70%), and the membrane potential was held
at 60 mV, unless stated otherwise. Signals were fed to a Pentium-based
PC through a DigiData 1320 interface board (Axon Instruments). pCLAMP
8 software (Axon Instruments) was used for stimulus generation, data display,
acquisition, and storage. In some experiments, we performed paired whole-
cell recordings from two CA1 pyramidal neurons (distance of the somas
<100 mm). Astrocytes were identified according to morphological and electro-
physiological criteria (e.g., Araque et al., 2002; Bergles et al., 2000; Bezzi et al.,
1998; Pasti et al., 1997; Perea and Araque, 2005) (Figure S2). ND experiments
started <30 min after entering whole-cell configuration. To test the ND effects
on the SIC frequency, the number of SICs recorded from each neuron during
50 s periods before (basal) and after the onset of the ND were compared. To
illustrate the time course of the effects of ND on the appearance of SICs in
Figure 7B, the number of SICs were grouped in 5 s bins, and the mean number
of SICs for each bin was calculated by averaging the values obtained from 16
paired recorded neurons from eight slices. Experiments were performed at
room temperature (22C–24C), unless stated otherwise. Data are expressed
asmean ±SEM.Statistical differenceswere establishedby theStudent’s t test.
Synaptic currents recorded from pyramidal neurons were evoked using
bipolar nichrome wire electrodes (80 mm diameter) that were connected to
a stimulator through isolation units (Grass S88, Quincy, MA) and placed in
the stratum radiatum near the border of the CA1 pyramidal neurons. IPSCs
were isolated in the presence of 20 mM CNQX and 50 mM AP5. Continuous
stimuli were delivered at 0.3 Hz. DSI was quantified from the mean amplitude
of three IPSCs after ND relative to the mean amplitude of 20 IPSCs before ND
(basal). Only slices in which the recorded neuron showed DSI after 5 s NDwere
considered.
Calcium Imaging
Ca2+ levels in astrocytes located in the stratum radiatum of the CA1 region of
the hippocampus were monitored by fluorescence microscopy using the Ca2+Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc. 891
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Endocannabinoids and Neuron-Astrocyte Signalingindicator fluo-4 (Molecular Probes, Eugene, OR). Slices were incubated with
fluo-4-AM (2–5 ml of 2 mM dye were dropped over the hippocampus, attaining
a final concentration of 2–10 mM and 0.01% of pluronic) for 20–30 min at room
temperature. Under these conditions, most of the cells loadedwere astrocytes
(Araque et al., 2002; Kang et al., 1998; Nett et al., 2002; Parri et al., 2001; Perea
and Araque, 2005), as confirmed in some cases by their electrophysiological
properties (see Figure S2). In some cases, Ca2+ levels in single astrocytes
were monitored by including fluo-4 in the recording pipette (Figures S2B and
S2C). Astrocytes were imaged using a CCD camera (Retiga EX; Qimaging,
Canada) attached to the Olympus microscope. Cells were illuminated during
200–500ms with a xenon lamp at 490 nm using amonochromator Polychrome
II (T.I.L.L. Photonics, Planegg, Germany), and images were acquired every
0.5–2 s. The monochromator Polychrome II and the CCD camera were con-
trolled and synchronized by the IP Lab software (BD Biosciences, MD) that
was also used for quantitative epifluorescencemeasurements. Ca2+ variations
recorded at the soma of the cells were estimated as changes of the fluores-
cence signal over baseline (DF/F0), and regions of interest were considered
to respond to the stimulation when DF/F0 increased three times the standard
deviation of the baseline for at least two consecutive images and with a delay
%15 s after the stimulation.
The astrocyte Ca2+ signal was quantified from the probability of occurrence
of a Ca2+ spike and the Ca2+ oscillation frequency. The Ca2+ spike probability
wascalculated from thenumberofCa2+elevations grouped in 5sbins recorded
from 6 to 14 astrocytes in the field of view. The time of occurrence was consid-
ered to be the onset of the Ca2+ spike. The Ca2+ oscillation frequency was
obtained from the number of Ca2+ spikes occurring in 6 to 14 astrocytes in
the field of viewduring 50 speriods before (basal) and after the onset of the neu-
ronal depolarization. To test the effects of ND on Ca2+ spike probability under
different conditions, the respective mean basal (50 s before ND) andmaximum
Ca2+ spike probability (i.e., 5–10 s after ND) from different sliceswere averaged
and compared. Mean values were obtained from at least four slices in each
condition.
UV-Flash Photolysis
In photostimulation experiments, pyramidal neurons were recorded with patch
pipettes filled with the internal solution containing 50 mM fluo-4 and 5 mM
NP-EGTA. For Ca2+ uncaging, train pulses (1ms duration, 6–15mW) of UV light
(340–380 nm) were delivered at 2 Hz during 5 s to the soma (optical window of
15–25 mm diameter) using a flash photolysis system (Rapp OptoElectronic,
Hamburg, Germany).
Immunocytochemistry
Anesthetized mice were perfused transcardially with 4% paraformaldehyde in
0.1 M phosphate buffer (PB). Brains were removed and postfixed in 4% para-
formaldehyde in 0.1 M PB for 3 hr. Coronal slices (35 mm thick) were cut with
a vibratome and processed to visualize the expression of CB1Rs and GFAP on
astrocytes. Slices were preincubated in 0.25% Triton X-100 with 3% normal
goat serum in PB during 2 hr, then were transferred to a new solution including
both rabbit polyclonal CB1R (dilution 1:250; Affinity Bioreagents) and mouse
monoclonal anti-GFAP-Cy3 conjugate antibody. Sections were incubated for
24 hr at 4C, rinsed in 0.1 M PB, and transferred to a solution containing the
secondary antibody, Alexa 488-conjugated goat anti-rabbit IgG (1:1000;
Molecular Probes). After washing, slices were mounted in glycerol (50% in
PB) and examined using laser-scanning confocal microscopy. Control exper-
iments for immunocytochemistry were performed in the absence of primary
antibody for CB1Rs, and no significant staining was detected under these
control conditions.
Drugs
N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyra-
zole-3-carboxamide (AM-251), arachidonylethanolamide (AEA), 6-cyano-7-
nitroquinoxaline-2,3-dione(CNQX), D(-)-2-amino-5-phosphonopentanoic acid
(AP5), 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP), 2-arachido-
nylglycerol (2AG), (S)-(+)-a-amino-4-carboxy-2-methylbenzeneacetic acid
(LY), (RS)-3-amino-2-(4-chlorophenyl)propylsulfonic acid (saclofen), and (R)-
(+)-methanandamide (MAEA) were purchased from Tocris Cookson (Bristol,892 Neuron 57, 883–893, March 27, 2008 ª2008 Elsevier Inc.UK). Tetrodotoxin (TTX) was acquired from Alomone Labs (Jerusalem, Israel).
Fluo-4-AM (Molecular Probes, Eugene, OR). All other drugs were from Sigma.
WIN, 2AG, AEA, andMAEAwere delivered by 2–5 s duration pressure pulses
(PMI-100 DAGAN, Minneapolis, MN) using a pulled capillary filled with WIN
(30–300 mM), 2AG (100 mM), AEA (300 mM), and MAEA (300 mM), dissolved in
ACSF. Based on quantification of the Alexa 594 fluorescence, we calculated
the pressure-ejected volume as 33 pl, and we estimated a 67% dilution
of the pipette solution in 100 mm3, which resulted in a final agonist concentra-
tion within the usual range of action (e.g., WIN concentration around the
recorded cell was1–10 mM). GABA (700 mM) was ionophoretically delivered.
Ionophoretical and pressure pulse experiments were performed in 1 mM TTX.
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/6/883/DC1/.
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